208 related articles for article (PubMed ID: 16099408)
1. Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors.
Lucas KK; Dennis EA
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):235-48. PubMed ID: 16099408
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
[TBL] [Abstract][Full Text] [Related]
3. Group-specific assays that distinguish between the four major types of mammalian phospholipase A2.
Yang HC; Mosior M; Johnson CA; Chen Y; Dennis EA
Anal Biochem; 1999 May; 269(2):278-88. PubMed ID: 10221999
[TBL] [Abstract][Full Text] [Related]
4. Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate.
Lio YC; Reynolds LJ; Balsinde J; Dennis EA
Biochim Biophys Acta; 1996 Jul; 1302(1):55-60. PubMed ID: 8695655
[TBL] [Abstract][Full Text] [Related]
5. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells.
Longo WE; Grossmann EM; Erickson B; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jun; 84(1):51-6. PubMed ID: 10334889
[TBL] [Abstract][Full Text] [Related]
6. Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2.
Lucas KK; Svensson CI; Hua XY; Yaksh TL; Dennis EA
Br J Pharmacol; 2005 Apr; 144(7):940-52. PubMed ID: 15685208
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjarvi T; Teräsvirta M; Uusitalo H
Mol Vis; 2007 Mar; 13():408-17. PubMed ID: 17417602
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta-induced substance P release from rat cultured primary afferent neurons driven by two phospholipase A2 enzymes: secretory type IIA and cytosolic type IV.
Morioka N; Takeda K; Kumagai K; Hanada T; Ikoma K; Hide I; Inoue A; Nakata Y
J Neurochem; 2002 Mar; 80(6):989-97. PubMed ID: 11953449
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability.
Forlenza OV; Mendes CT; Marie SK; Gattaz WF
Prostaglandins Leukot Essent Fatty Acids; 2007 Jan; 76(1):47-55. PubMed ID: 17187973
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1.
Thommesen L; Sjursen W; Gåsvik K; Hanssen W; Brekke OL; Skattebøl L; Holmeide AK; Espevik T; Johansen B; Laegreid A
J Immunol; 1998 Oct; 161(7):3421-30. PubMed ID: 9759860
[TBL] [Abstract][Full Text] [Related]
11. Activities and interactions among phospholipases A2 during thapsigargin-induced S49 cell death.
Wilson HA; Allred DV; O'Neill K; Bell JD
Apoptosis; 2000 Oct; 5(4):389-96. PubMed ID: 11227220
[TBL] [Abstract][Full Text] [Related]
12. Continuous, vesicle-based fluorimetric assays of 14- and 85-kDa phospholipases A2.
Bayburt T; Yu BZ; Street I; Ghomashchi F; Laliberté F; Perrier H; Wang Z; Homan R; Jain MK; Gelb MH
Anal Biochem; 1995 Nov; 232(1):7-23. PubMed ID: 8600835
[TBL] [Abstract][Full Text] [Related]
13. Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells.
Balboa MA; Shirai Y; Gaietta G; Ellisman MH; Balsinde J; Dennis EA
J Biol Chem; 2003 Nov; 278(48):48059-65. PubMed ID: 12963740
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid.
Wong RK; Pettit AI; Quinn PA; Jennings SC; Davies JE; Ng LL
Circulation; 2003 Oct; 108(15):1858-64. PubMed ID: 12963645
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells.
Kell PJ; Creer MH; Crown KN; Wirsig K; McHowat J
J Pharmacol Exp Ther; 2003 Dec; 307(3):1163-70. PubMed ID: 14560038
[TBL] [Abstract][Full Text] [Related]
16. Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons.
Mendes CT; Gattaz WF; Schaeffer EL; Forlenza OV
J Neural Transm (Vienna); 2005 Oct; 112(10):1297-308. PubMed ID: 15682269
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids differentially inhibit guinea pig epidermal cytosolic phospholipase A2.
Kim HR; Pham HT; Ziboh VA
Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):281-6. PubMed ID: 11993721
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2.
Basavarajappa BS; Cooper TB; Hungund BL
Biochem Pharmacol; 1998 Feb; 55(4):515-21. PubMed ID: 9514087
[TBL] [Abstract][Full Text] [Related]
19. Assaying phospholipase A2 activity.
Leslie CC; Gelb MH
Methods Mol Biol; 2004; 284():229-42. PubMed ID: 15173620
[TBL] [Abstract][Full Text] [Related]
20. A secretory PLA2 associated with tobacco hornworm hemocyte membrane preparations acts in cellular immune reactions.
Park Y; Aliza AR; Stanley D
Arch Insect Biochem Physiol; 2005 Nov; 60(3):105-15. PubMed ID: 16235259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
